Sign In
Buy LH
$309.20
-6.33 (-2.01%)
At Close: Jul 31, 2026
Chemed (CHE) Q2 Earnings Beat Estimates, Margins Decline
02:02pm, Thursday, 30'th Jul 2020
Chemed (CHE) witnesses solid revenue growth across key subsidiaries in Q2 earnings.
Results: Laboratory Corporation of America Holdings Beat Earnings Expectations And Analysts Now Have New Forecasts
01:55pm, Thursday, 30'th Jul 2020
Laboratory Corporation of America Holdings (NYSE:LH) defied analyst predictions to release its second-quarter results...
CONMED (CNMD) Q2 Loss Narrower Than Expected, Revenues Top
01:23pm, Thursday, 30'th Jul 2020
CONMED's (CNMD) core units - General Surgery and Orthopedic Surgery - witnessed revenue decline in Q2.
Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise
01:20pm, Thursday, 30'th Jul 2020
Hologic (HOLX) exhibited robust segmental growth in third-quarter fiscal 2020 driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.
Omnicell (OMCL) Q2 Earnings Lag Estimates, Margins Down
01:54pm, Wednesday, 29'th Jul 2020
Omnicell's (OMCL) second-quarter revenues suffered due to slowdown in hospital purchasing decisions and product bookings owing to pandemic-led business disruptions.
LabCorp (LH) Hits 52-Week High, Can the Run Continue?
01:15pm, Wednesday, 29'th Jul 2020
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Laboratory Corp Of America Holdings (LH) Q2 2020 Earnings Call Transcript
07:30pm, Tuesday, 28'th Jul 2020
LH earnings call for the period ending June 30, 2020.
How LabCorp Beat Wall Street's Q2 Estimates
07:00pm, Tuesday, 28'th Jul 2020
Laboratory Corporation of America Holdings (NYSE: LH) has sailed through the turbulent waters of 2020 pretty well so far. Here are the highlights from the company's Q2 update. LabCorp reported Q2 re
LabCorp (LH) Beats Q2 Earnings Estimates, Margins Decline
03:41pm, Tuesday, 28'th Jul 2020
LabCorp (LH) witnesses a 20.7% decline in organic volume, partially offset by acquisition volume growth of 1.2%.
Is Laboratory Corporation of America Holdings (LH) Outperforming Other Medical Stocks This Year?
03:30pm, Tuesday, 28'th Jul 2020
Is (LH) Outperforming Other Medical Stocks This Year?
LabCorp says need to run testing below full capacity to maintain shorter turnaround time
02:21pm, Tuesday, 28'th Jul 2020Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q2 2020 Results - Earnings Call Transcript
01:20pm, Tuesday, 28'th Jul 2020
Laboratory Corporation of America Holdings (NYSE:LH) Q2 2020 Results Conference Call July 28, 2020 09:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - Chairman and CEO Glenn Ei
LabCorp (LH) Q2 Earnings and Revenues Top Estimates
12:25pm, Tuesday, 28'th Jul 2020
LabCorp (LH) delivered earnings and revenue surprises of 229.49% and 14.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Weitz Investment Management Q2 2020 Commentary
12:15pm, Thursday, 23'rd Jul 2020
Founded by value investor Wally Weitz in 1983, Weitz Investment Management, Inc. is a boutique, employee-owned asset management firm headquartered in Omaha, Nebraska.
Laboratory Corporation Of America: Reasonably Priced And Positioned For Growth
09:14am, Thursday, 23'rd Jul 2020
Laboratory Corporation of America operates as one of the top two providers of clinical lab testing services.
